Market Indices
Sector Heatmap
ALNY — Alnylam Pharmaceuticals, Inc.
NasdaqAlnylam Pharmaceuticals, Inc.
- O
- 248.21
- H
- 251.71
- L
- 230.06
- V
- 2.01M
ALNY — Latest News & Headlines
20 StoriesAlnylam Pharmaceuticals, Inc. (ALNY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price, News, Quote & History Yahoo! Finance Canada
Alnylam Pharmaceuticals (ALNY) Stock Looks Above Fair Value As Shares Fell 49% - simplywall.st
Alnylam Pharmaceuticals (ALNY) Stock Looks Above Fair Value As Shares Fell 49% simplywall.st
A former football player’s symptoms were attributed to football or aging. His heart diagnosis came late. - Stock Titan
A former football player’s symptoms were attributed to football or aging. His heart diagnosis came late. Stock Titan
Alnylam Shares Fall as Investors Weigh Earlier 2026 Outlook Reset Against a Near-Term Data Wait - Quiver Quantitative
Alnylam Shares Fall as Investors Weigh Earlier 2026 Outlook Reset Against a Near-Term Data Wait Quiver Quantitative
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform (NASDAQ:ALNY) - Seeking Alpha
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform (NASDAQ:ALNY) Seeking Alpha
Here's How Much $100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today - Benzinga
Here's How Much $100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today Benzinga
Alnylam Pharmaceuticals (ALNY) Short Interest & Short Float | Updated Sep 2026 $ALNY - MarketBeat
Alnylam Pharmaceuticals (ALNY) Short Interest & Short Float | Updated Sep 2026 $ALNY MarketBeat
ALNY Maintains by JP Morgan -- Price Target Lowered to $369 - GuruFocus
ALNY Maintains by JP Morgan -- Price Target Lowered to $369 GuruFocus
Trading the Move, Not the Narrative: (ALNY) Edition - Stock Traders Daily
Trading the Move, Not the Narrative: (ALNY) Edition Stock Traders Daily
Truist reiterates Alnylam stock rating on hypertension drug potential - Investing.com
Truist reiterates Alnylam stock rating on hypertension drug potential Investing.com
Alnylam Needs Stronger AMVUTTRA Execution To Justify More Upside (NASDAQ:ALNY) - Seeking Alpha
Alnylam Needs Stronger AMVUTTRA Execution To Justify More Upside (NASDAQ:ALNY) Seeking Alpha
ALNY Mar 2027 110.000 call (ALNY270319C00110000) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALNY Mar 2027 110.000 call (ALNY270319C00110000) Stock Price, News, Quote & History Yahoo! Finance Canada
Will RNAi Market Growth Change Alnylam Stock's Narrative? - simplywall.st
Will RNAi Market Growth Change Alnylam Stock's Narrative? simplywall.st
ALNY Oct 2026 175.000 put (ALNY261016P00175000) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALNY Oct 2026 175.000 put (ALNY261016P00175000) Stock Price, News, Quote & History Yahoo! Finance Canada
ALNY Mar 2027 195.000 call (ALNY270319C00195000) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALNY Mar 2027 195.000 call (ALNY270319C00195000) Stock Price, News, Quote & History Yahoo! Finance Canada
ALNY Oct 2026 340.000 put (ALNY261016P00340000) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALNY Oct 2026 340.000 put (ALNY261016P00340000) Stock Price, News, Quote & History Yahoo! Finance Canada
ALNY261016P00210000 Interactive Stock Chart | ALNY Oct 2026 210.000 put Stock - Yahoo Finance
ALNY261016P00210000 Interactive Stock Chart | ALNY Oct 2026 210.000 put Stock Yahoo Finance
ALNY Oct 2026 210.000 put (ALNY261016P00210000) interactive stock chart - Yahoo Finance UK
ALNY Oct 2026 210.000 put (ALNY261016P00210000) interactive stock chart Yahoo Finance UK
ALNY Mar 2027 470.000 call (ALNY270319C00470000) interactive stock chart - Yahoo Finance UK
ALNY Mar 2027 470.000 call (ALNY270319C00470000) interactive stock chart Yahoo Finance UK
FDA, Duke-Margolis workshop to examine evidence standards for rare diseases (XBI:NYSEARCA) - Seeking Alpha
FDA, Duke-Margolis workshop to examine evidence standards for rare diseases (XBI:NYSEARCA) Seeking Alpha